Zhengye Biotechnology Holding Ltd
ZYBT
Company Profile
Business description
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry, and other vaccines.
Contact
No. 1 Lianmeng Road
Jilin Economic & Technical Development Zone
Jilin Province
Jilin City
CHNT: +86 43263047008
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
277
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,018.80 | 0.80 | -0.01% |
| CAC 40 | 8,149.50 | 18.65 | -0.23% |
| DAX 40 | 24,490.41 | 139.29 | 0.57% |
| Dow JONES (US) | 48,209.01 | 158.05 | -0.33% |
| FTSE 100 | 9,931.38 | 9.33 | -0.09% |
| HKSE | 25,630.54 | 224.06 | -0.87% |
| NASDAQ | 23,358.45 | 60.63 | -0.26% |
| Nikkei 225 | 50,339.48 | 187.44 | -0.37% |
| NZX 50 Index | 13,548.42 | 0.29 | 0.00% |
| S&P 500 | 6,876.22 | 20.02 | -0.29% |
| S&P/ASX 200 | 8,714.30 | 0.50 | -0.01% |
| SSE Composite Index | 3,968.84 | 3.72 | 0.09% |